| For: | Hu JW, Pan YZ, Zhang XX, Li JT, Jin Y. Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers. World J Gastroenterol 2025; 31(20): 106747 [PMID: 40495940 DOI: 10.3748/wjg.v31.i20.106747] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i20/106747.htm |
| Number | Citing Articles |
| 1 |
Maryam Sadat Mirlohi, Tooba Yousefi, Amir Reza Aref, Amir Seyfoori. Integrating New Approach Methodologies (NAMs) into Preclinical Regulatory Evaluation of Oncology Drugs. Biomimetics 2025; 10(12): 796 doi: 10.3390/biomimetics10120796
|
| 2 |
Sam Jacobs, William Butterworth, Ewen A Griffiths. Patient-derived organoids in hepatobiliary pancreatic cancer research: Their uses and limitations. World Journal of Gastroenterology 2025; 31(36): 110684 doi: 10.3748/wjg.v31.i36.110684
|
| 3 |
Wonmin Lee, Hyun-Myung Woo, Ja Hyang Cho, Man S. Kim. Complementary strategies in pancreatic cancer precision medicine: therapeutic prediction and immune modulation. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1718911
|
